Synapse - Joachim Yahalom

Results (99)

Safety and early data from a phase II trial of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (Hl) and follicular lymphoma (FL)

Meeting Abstract

Sermer, D.; Vardhana, S.; Batlevi, C.; Hamilton, A.; Moskowitz, A.; Caron, P.; Moskowitz, C.; Matasar, M.; Biggar, E.; Leung, E.; more...
Hematological Oncology (2019)

Fulltext@MSK | Save

Incidence and treatment outcomes of patients with transformed marginal zone lymphoma treated with RCHOP‐like regimens

Meeting Abstract

Rajeeve, S.; Bobillo, S. V.; Zelenetz, A. D.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; Moskowitz, A. J.; Hamlin, P. A.; Matasar, M. J.; more...
Hematological Oncology (2019)

Fulltext@MSK | Save

Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era

Meeting Abstract

Bobillo, S.; Joffe, E.; Lavery, J.; Noy, A.; Palomba, L.; Straus, D. J.; Kumar, A.; Batlevi, C.; Horwitz, S.; Moskowitz, A.; more...
Hematological Oncology (2019)

Fulltext@MSK | Save

Outcomes of relapsed and refractory primary mediastinal (thymic) large B cell lymphoma treated with second-line therapy and intent to transplant

Journal Article

Vardhana, S.; Hamlin, P. A.; Yang, J.; Zelenetz, A.; Sauter, C. S.; Matasar, M. J.; Ni, A.; Yahalom, J.; Moskowitz, C. H.
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Outcome after radiation therapy for Langerhans cell histiocytosis is dependent on site of involvement

Journal Article

Laird, J.; Ma, J.; Chau, K.; Chelius, M.; Shi, W.; Zhang, Z.; Lok, B. H.; Yahalom, J.
International Journal of Radiation Oncology, Biology, Physics (2018)

Fulltext@MSK | Save

Early toxicities associated with radiation based conditioning for relapsed/refractory Hodgkin lymphoma patients undergoing high dose therapy and autologous stem cell transplantation (HDT-ASCT)

Meeting Abstract

Shah, G. L.; Scordo, M.; Devlin, S. M.; Yahalom, J.; Matasar, M. J.; Moskowitz, A.; Giralt, S. A.; Moskowitz, C. H.
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Cost-effectiveness analysis of first-line treatments for early-stage, low-grade follicular lymphoma

Meeting Abstract

Yang, J. C.; Elkin, E. B.; Parikh, R.; Yahalom, J.
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma

Meeting Abstract

Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Chen, R. W.; Constine, L. S.; Courtien, A.; more...
Blood (2017)

Fulltext@MSK | Save

Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma

Journal Article

Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
Blood (2017)

Fulltext@MSK | Save

Langerhans cell histiocytosis in adults is associated with additional solid and hematologic malignancies

Meeting Abstract

Ma, J.; Laird, J.; Chau, K.; Chelius, M.; Bell, A. C.; Zheng, J.; Zhang, Z.; Lok, B. H.; Yahalom, J.
Pediatric Blood and Cancer (2017)

Fulltext@MSK | Save